Inactive Instrument

News HTG Molecular Diagnostics Inc Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
-	-

2023	Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc.	CI
2023	Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc.	23-08-25	CI
Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc.	23-08-16	CI
Trustee/Examiner Appointed Under Chapter 11 for HTG Molecular Diagnostics, Inc.	23-07-21	CI
HTG Molecular Diagnostics, Inc.(OTCPK:HTGM.Q) dropped from NASDAQ Composite Index	23-06-14	CI
HTG MOLECULAR DIAGNOSTICS, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	23-06-08	AQ
HTG Molecular Diagnostics, Inc.(NasdaqCM:HTGM) dropped from S&P TMI Index	23-06-08	CI
Htg Molecular Diagnostics, Inc. Announces Termination of Employment of Byron T. Lawson as Senior Vice President and Chief Commercial Officer	23-06-05	CI
HTG Molecular Diagnostics, Inc. Filed for Bankruptcy	23-06-05	CI
HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention	23-05-18	AQ
HTG Molecular Diagnostics, Inc. to Highlight the Advantages of its Drug Discovery Engine at the 2023 Biotechnology Innovation Organization	23-05-18	CI
Top Premarket Gainers	23-05-17	MT
HTG Highlights the Advantages of Its Drug Discovery Engine	23-05-16	AQ
HTG Molecular Diagnostics : Reports First Quarter 2023 Results and Provides Recent Business Highlights - Form 8-K	23-05-10	PU
HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights	23-05-10	AQ
HTG MOLECULAR DIAGNOSTICS, INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-10	AQ
HTG Molecular Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
HTG MOLECULAR DIAGNOSTICS, INC : Other Events (form 8-K)	23-04-25	AQ
HTG Provides Update on Drug Discovery Partnering Initiative	23-04-25	AQ
HTG Announces Key First Quarter Milestone Achievements for Drug Discovery	23-04-18	AQ
HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19	23-04-06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News HTG Molecular Diagnostics Inc Nasdaq

Equities

Summary

Filters